Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.67 EUR | +0.30% | -.--% | +3.09% |
Mar. 15 | Naturhouse Health, S.A. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
2023 | Naturhouse Health, S.A. Reports Earnings Results for the Half Year Ended June 30, 2023 | CI |
Valuation
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Capitalization 1 | 119.7 | 92.92 | 115.4 | 94.42 | 97.12 | 100.1 | - | - |
Enterprise Value (EV) 1 | 119.7 | 92.92 | 92.52 | 84.43 | 97.12 | 77.12 | 75.12 | 74.02 |
P/E ratio | - | - | 8.75 x | 9.84 x | 8.53 x | 9.82 x | 9.82 x | 9.82 x |
Yield | - | - | 3.12% | 9.52% | - | 8.38% | 8.38% | 8.38% |
Capitalization / Revenue | 1.47 x | 1.69 x | 2 x | 1.8 x | 1.93 x | 2 x | 1.96 x | 1.91 x |
EV / Revenue | 1.47 x | 1.69 x | 1.61 x | 1.61 x | 1.93 x | 1.54 x | 1.47 x | 1.41 x |
EV / EBITDA | 5.21 x | 5.64 x | 4.67 x | 5.37 x | - | 4.73 x | 4.55 x | 4.46 x |
EV / FCF | - | - | 5.74 x | 13.8 x | - | 8.03 x | 7.99 x | 7.71 x |
FCF Yield | - | - | 17.4% | 7.26% | - | 12.4% | 12.5% | 13% |
Price to Book | - | - | - | - | - | - | - | - |
Nbr of stocks (in thousands) | 59,950 | 59,949 | 59,949 | 59,949 | 59,949 | 59,949 | - | - |
Reference price 2 | 1.996 | 1.550 | 1.925 | 1.575 | 1.620 | 1.670 | 1.670 | 1.670 |
Announcement Date | 2/28/20 | 3/1/21 | 2/28/22 | 2/28/23 | 3/15/24 | - | - | - |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Net sales 1 | 81.67 | 55.08 | 57.59 | 52.4 | 50.41 | 50 | 51 | 52.4 |
EBITDA 1 | 22.98 | 16.48 | 19.8 | 15.72 | - | 16.3 | 16.5 | 16.6 |
EBIT 1 | 18.69 | 13.22 | 17.34 | 12.85 | 16.26 | 14.1 | 14.3 | 14.3 |
Operating Margin | 22.89% | 24.01% | 30.1% | 24.53% | 32.27% | 28.2% | 28.04% | 27.29% |
Earnings before Tax (EBT) 1 | - | - | 18.24 | 13.1 | 15.42 | 14.1 | 14.3 | 14.4 |
Net income 1 | - | - | 13.36 | 9.627 | 11.29 | 10.3 | 10.5 | 10.5 |
Net margin | - | - | 23.2% | 18.37% | 22.4% | 20.6% | 20.59% | 20.04% |
EPS 2 | - | - | 0.2200 | 0.1600 | 0.1900 | 0.1700 | 0.1700 | 0.1700 |
Free Cash Flow 1 | - | - | 16.12 | 6.133 | - | 9.6 | 9.4 | 9.6 |
FCF margin | - | - | 27.99% | 11.7% | - | 19.2% | 18.43% | 18.32% |
FCF Conversion (EBITDA) | - | - | 81.45% | 39.02% | - | 58.9% | 56.97% | 57.83% |
FCF Conversion (Net income) | - | - | 120.67% | 63.71% | - | 93.2% | 89.52% | 91.43% |
Dividend per Share 2 | - | - | 0.0600 | 0.1500 | - | 0.1400 | 0.1400 | 0.1400 |
Announcement Date | 2/28/20 | 3/1/21 | 2/28/22 | 2/28/23 | 3/15/24 | - | - | - |
Balance Sheet Analysis
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Net Debt 1 | - | - | - | - | - | - | - | - |
Net Cash position 1 | - | - | 22.9 | 9.99 | - | 23 | 25 | 26.1 |
Leverage (Debt/EBITDA) | - | - | - | - | - | - | - | - |
Free Cash Flow 1 | - | - | 16.1 | 6.13 | - | 9.6 | 9.4 | 9.6 |
ROE (net income / shareholders' equity) | - | - | 43% | 30.1% | - | 32.9% | 31.3% | 29.2% |
ROA (Net income/ Total Assets) | - | - | - | - | - | - | - | - |
Assets 1 | - | - | - | - | - | - | - | - |
Book Value Per Share | - | - | - | - | - | - | - | - |
Cash Flow per Share | - | - | - | - | - | - | - | - |
Capex 1 | - | - | 0.05 | 0.96 | - | 0.6 | 0.6 | 0.6 |
Capex / Sales | - | - | 0.09% | 1.84% | - | 1.2% | 1.18% | 1.15% |
Announcement Date | 2/28/20 | 3/1/21 | 2/28/22 | 2/28/23 | 3/15/24 | - | - | - |
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+3.09% | 107M | |
+26.16% | 29.47B | |
+5.74% | 5.74B | |
-13.09% | 4.33B | |
+16.16% | 4.25B | |
+4.23% | 1.87B | |
-6.92% | 1.69B | |
-13.95% | 1.26B | |
-20.33% | 1.14B | |
-40.09% | 725M |
- Stock Market
- Equities
- NTH Stock
- Financials Naturhouse Health, S.A.